Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 17, 2026
Why Is Synopsys (SNPS) Stock Down -10.82% Today?

Why Is Synopsys (SNPS) Stock Down -10.82% Today?

Key Takeaways

  • SNPS shares plunged approximately 10.82% in Friday trading, dropping from a prior close of $417.03 to around $371.92 intraday.
  • The steep selloff occurred despite Benchmark initiating coverage with a Buy rating and a $570 price target, underscoring how detached positive analyst sentiment has become from near-term price action.
  • Broader weakness across the electronic design automation (EDA) sector compounded the pressure, with peer CDNS (Cadence Design Systems) also trading lower in sympathy.
  • The stock broke decisively below a well-established support zone between $396 and $438 that had held through six prior drawdowns, triggering technical selling and stop-loss cascades.
  • SNPS has now shed roughly 19% since its May 27 earnings beat, reflecting persistent concerns around valuation, post-Ansys integration execution, and softening demand in non-AI semiconductor end markets.

Opening Summary

Synopsys, Inc. (SNPS), the Sunnyvale, California-based leader in electronic design automation software and semiconductor design IP, saw its shares suffer a dramatic intraday rout on Friday. The stock tumbled approximately 10.82%, falling from Wednesday's close of $417.03 to trade near $371.92 during the session. The decline marks one of the sharpest single-day selloffs for the semiconductor design software giant in recent memory and comes despite a fresh Buy initiation from Benchmark — highlighting a growing divergence between Wall Street's long-term conviction and the market's near-term appetite for richly valued technology names.

Benchmark Buy Rating Fails to Stem the Tide

In a striking illustration of how sentiment has soured on the stock, Benchmark initiated research coverage on SNPS with a Buy rating and a $570 price target — implying upside of more than 50% from Friday's depressed levels. The analyst note highlighted Synopsys' dominant position in the EDA duopoly alongside CDNS, emphasizing high barriers to entry, strong pricing power, and the company's critical role in AI-driven chip design and data center infrastructure. Yet the stock not only failed to rally on the news but accelerated its decline, a signal that institutional sellers and momentum-driven traders are currently exerting far greater influence on price than fundamental research reports.

Breaking a Floor That Held Six Times Before

Perhaps the most consequential technical development in Friday's selloff was the clean break below a support zone spanning roughly $396 to $438 — a price band that had served as a reliable floor through six separate drawdowns dating back to 2023. Each previous visit to this zone had been met with aggressive buying, producing rebounds averaging 31%. The decisive violation of this level, with SNPS trading into the low $370s, likely triggered a cascade of stop-loss orders and forced repositioning by momentum-driven funds. Volume during the session ran well above recent daily averages, consistent with liquidation-style selling rather than orderly rotation.

Post-Earnings Drift Turns Into a Rout

Friday's plunge extends a persistent selloff that began immediately after the company's fiscal second-quarter earnings report on May 27. That report was objectively strong: revenue of $2.28 billion beat consensus estimates by roughly $30 million, non-GAAP EPS of $3.35 topped the $3.15 Street forecast, and management raised full-year FY2026 guidance for revenue, margins, and earnings. Free cash flow surged to $575 million, crushing the $247 million analyst estimate. CEO Sassine Ghazi pointed to AI-driven demand as a powerful tailwind and noted operating margins expanding more than 300 basis points year over year. Despite all this, SNPS stock has fallen approximately 19% from its post-earnings levels, a disconnect that has frustrated bulls and emboldened skeptics.

Valuation Concerns Weigh on Sentiment

At the heart of the selloff is a valuation debate that has grown louder as the broader market has rotated away from premium-multiple technology names. Even after Friday's decline, SNPS carries a trailing price-to-earnings ratio north of 90, well above the software industry average. While bulls argue that the Ansys acquisition, closed in mid-2025, will drive multi-year revenue and cost synergies that justify the premium, skeptics point to the heavy GAAP amortization burden — $403.6 million in quarterly intangible amortization alone — that obscures true profitability. With the stock trading below both its 50-day and 200-day moving averages, and the broader semiconductor sector under pressure, the market appears unwilling to pay for future synergies today.

Muted Non-AI Demand Adds to Uncertainty

Management acknowledged during the Q2 earnings call that outside the AI-driven segment of the business, design activity in key verticals such as industrial and automotive remains "fairly muted." The Design IP segment, while showing sequential improvement, was still down approximately 6% year over year in the latest quarter. This "tale of two cities" dynamic — explosive AI-related demand alongside softness in traditional end markets — leaves SNPS exposed to any slowdown in AI spending growth, a risk that traders appear increasingly unwilling to overlook.

Market Context and Trading Activity

Friday's selloff in SNPS was not occurring in isolation. Peer CDNS (Cadence Design Systems) also traded lower, indicating sector-wide pressure rather than a company-specific event. The semiconductor design software space has been under steady distribution for weeks, with both stocks carving a pattern of lower highs and lower lows since early July. Broader technology indices also experienced headwinds, and the rotation out of high-beta, high-multiple software names appeared to accelerate in Friday's session. SNPS' elevated trading volume confirmed institutional-scale selling rather than retail-driven noise.

Trending AI Robots

Traders seeking systematic, data-driven approaches to navigate volatile markets like today's may find value in Tickeron's Trending AI Robots platform. Tickeron offers hundreds of AI-powered trading bots that analyze thousands of tickers across multiple timeframes and strategies, but only the strongest performers under current market conditions are curated into the Trending AI Robots section. These bots vary by strategy type — from swing trading to trend following — as well as by performance metrics, holding periods, and the specific symbols they trade. For those looking to complement their own analysis with algorithmic insight, exploring the Trending AI Robots page offers a window into which strategies are currently delivering results in real market conditions.

What Comes Next for SNPS

The next major catalyst for SNPS is its fiscal third-quarter earnings report, estimated for around August 19, 2026. The company guided Q3 revenue between $2.41 billion and $2.46 billion, with non-GAAP EPS in the range of $3.63 to $3.69. Analysts will be closely scrutinizing the Design IP segment for confirmation that the recovery flagged by management is materializing, as well as any updates to the Ansys integration timeline and synergy targets. A September investor day, expected to provide longer-term financial targets, represents another potential inflection point. Key risks include any deceleration in AI-driven chip design spending, execution challenges with the Ansys merger, and further softening in industrial and automotive semiconductor demand. Conversely, a stronger-than-expected IP recovery or upward guidance revision could begin to close the widening gap between the company's operational performance and its battered share price.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SNPS

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


SNPS in upward trend: price rose above 50-day moving average on September 21, 2026

SNPS moved above its 50-day moving average on September 21, 2026 date and that indicates a change from a downward trend to an upward trend. In 24 of 31 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 21, 2026. You may want to consider a long position or call options on SNPS as a result. In 55 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 70%.

The Moving Average Convergence Divergence (MACD) for SNPS just turned positive on September 22, 2026. Looking at past instances where SNPS's MACD turned positive, the stock continued to rise in 33 of 45 cases over the following month. The odds of a continued upward trend are 73%.

The 10-day moving average for SNPS crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.

Following a +18.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where SNPS advanced for three days, in 249 of 339 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

The Aroon Indicator entered an Uptrend today. In 151 of 240 cases where SNPS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNPS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.

SNPS broke above its upper Bollinger Band on October 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 29 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. SNPS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.569) is normal, around the industry mean (18.522). P/E Ratio (72.881) is within average values for comparable stocks, (158.311). Projected Growth (PEG Ratio) (2.237) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (7.675) is also within normal values, averaging (104.490).

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Twilio (NYSE:TWLO), Block Inc (NYSE:XYZ), NetApp (NASDAQ:NTAP), Okta (NASDAQ:OKTA), Zscaler (NASDAQ:ZS), MongoDB (NASDAQ:MDB).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 35.56B. The market cap for tickers in the group ranges from 48.8K to 3.78T. MSFT holds the highest valuation in this group at 3.78T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was 1%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 21%. BIRD experienced the highest price growth at 46%, while VERI experienced the biggest fall at -43%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -1%. For the same stocks of the Industry, the average monthly volume growth was -27% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 70
Price Growth Rating: 57
SMR Rating: 78
Profit Risk Rating: 91
Seasonality Score: 3 (-100 ... +100)
View a ticker or compare two or three
SNPS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of software based designing solutions for the semiconductor industry

Industry ComputerCommunications

Industry
Packaged Software
Address
675 Almanor Avenue
Phone
+1 650 584-5000
Employees
28000
Web
https://www.synopsys.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
Why Is Synopsys (SNPS) Stock Down -10.82% Today?